Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to expect from LLY's Q1 results.

There are also many well-known stand-alone pet insurance providers, including Lemonade, ASPCA Pet Health Insurance, Healthy ...